GAPDH and ovarian carcinoma: Frequent somatic mutations in the 3′-UTR of GAPDH have been reported to promote the growth of ovarian cancer by sponging miR-125 and thereby affecting the expression of Signal Transducer and Activator of Transcription 3 (STAT3) (Liu et al., 2020).